We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

66 hedge funds and large institutions have $145M invested in Kindred Biosciences, Inc. in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 10

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

46% more call options, than puts

Call options by funds: $35K | Put options by funds: $24K

42% more capital invested

Capital invested by funds: $101M → $145M (+$43M)

38% more funds holding

Funds holding: 48 → 66 (+18)

Holders
66
Holders Change
+18
Holders Change %
+37.5%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
20
Reduced
10
Closed
10
Calls
$35K
Puts
$24K
Net Calls
+$11K
Net Calls Change
+$107K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.07M
2
CC
Cannell Capital
Wyoming
+$2.73M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.24M
4
AL
AJO LP
Pennsylvania
+$2.01M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$7.28M
2
Bank of America
Bank of America
North Carolina
-$518K
3
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$415K
4
Millennium Management
Millennium Management
New York
-$276K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$210K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$39.2M +$1.22M +170,387 +4%
Morgan Stanley
2
Morgan Stanley
New York
$18.1M +$552K +76,978 +4%
AI
3
Ariel Investments
Illinois
$16.9M -$7.28M -1,014,410 -34%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$11.8M -$3.33K -464 -0%
BlackRock
5
BlackRock
New York
$8.12M +$6.07M +845,813 +856%
Renaissance Technologies
6
Renaissance Technologies
New York
$7.02M +$2.24M +311,800 +62%
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.41M +$1.96M +272,612 +58%
EC
8
EcoR1 Capital
California
$4.69M – – –
CC
9
Cannell Capital
Wyoming
$3.27M +$2.73M +379,874 New
Wells Fargo
10
Wells Fargo
California
$2.84M +$3.59K +500 +0.2%
AL
11
AJO LP
Pennsylvania
$2.41M +$2.01M +279,920 New
State Street
12
State Street
Massachusetts
$2.21M +$1.84M +257,095 New
AFS
13
Amtrust Financial Services
New York
$2.15M – – –
Deutsche Bank
14
Deutsche Bank
Germany
$2M +$1.2M +166,751 +255%
New York State Common Retirement Fund
15
New York State Common Retirement Fund
New York
$1.92M -$415K -57,801 -21%
Northern Trust
16
Northern Trust
Illinois
$1.83M +$1.33M +184,770 +648%
GIP
17
Granite Investment Partners
California
$1.21M -$48.5K -6,766 -5%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.19M +$495K +69,037 +100%
RA
19
Royce & Associates
New York
$1.08M – – –
Citigroup
20
Citigroup
New York
$707K +$590K +82,192 New
Connor, Clark & Lunn Investment Management (CC&L)
21
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$678K +$59.2K +8,250 +12%
UBS Group
22
UBS Group
Switzerland
$572K +$9.88K +1,378 +2%
EI
23
EAM Investors
California
$563K +$470K +65,487 New
GIM
24
Granahan Investment Management
Massachusetts
$547K +$456K +63,590 New
TCIM
25
TIAA CREF Investment Management
New York
$547K +$457K +63,636 New
1
2 3 4

KIN Hedge Fund Activity: Q2 2017 in Review

66 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q2 2017, worth a combined $145M — up 42% from $101M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new KIN positions and 10 closed out — a net gain of 18 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $6.07M. The largest seller was Ariel Investments, cutting an estimated $7.28M.

  • 66 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q2 2017, up from 48 in Q1 2017.
  • Funds reported $145M of Kindred Biosciences, Inc. stock for Q2 2017, up 42% quarter-over-quarter.
  • 28 funds opened new Kindred Biosciences, Inc. positions in Q2 2017 and 10 closed out, a net change of +18 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q2 2017 was BlackRock, an estimated $6.07M added.
  • The largest Kindred Biosciences, Inc. seller in Q2 2017 was Ariel Investments, an estimated $7.28M sold.

Based on aggregated 13F filings for Q2 2017.